The use of carrageenan as a granuloma-producing agent in Freund's adjuvant.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000921:Antibody-Producing Cells / Q000187:drug effects; D000941:Antigens; D002351:Carrageenan / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D005620:Freund's Adjuvant; D006099:Granuloma / Q000139:chemically induced*; D006168:Guinea Pigs; D006965:Hyperplasia; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D007106:Immune Sera; D007115:Immunization Schedule; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008198:Lymph Nodes / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects; D009169:Mycobacterium tuberculosis; D012882:Skin Tests
D000941:Antigens; D007106:Immune Sera; D007166:Immunosuppressive Agents; D002351:Carrageenan; D005620:Freund's Adjuvant